Aptevo Therapeutics Inc. Operating Expenses
Aptevo Therapeutics Inc. (APVO) reported Operating Expenses of $7.28 million for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2020-08-14
- Aptevo Therapeutics Inc. operating expenses for the quarter ending 2020-06-30 was $7.28M, a 30.03% decline year-over-year.
- Aptevo Therapeutics Inc. operating expenses for the quarter ending 2020-03-31 was $7.62M, a 31.71% decline year-over-year.
- Aptevo Therapeutics Inc. operating expenses for the quarter ending 2019-06-30 was $10.40M.
- Aptevo Therapeutics Inc. operating expenses for the quarter ending 2019-03-31 was $11.16M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month |
|---|---|---|
| 2020-06-30 | $7.28M 10-Q · filed 2020-08-14 | $14.90M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $7.62M 10-Q · filed 2020-05-13 | |
| 2019-06-30 | $10.40M 10-Q · filed 2020-08-14 | $21.57M 10-Q · filed 2020-08-14 |
| 2019-03-31 | $11.16M 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |